Literature DB >> 6630509

Formation of diiodotyrosine from thyroxine. Ether-link cleavage, an alternate pathway of thyroxine metabolism.

A Balsam, F Sexton, M Borges, S H Ingbar.   

Abstract

Studies were performed to elucidate the nature of the pathway of hepatic thyroxine (T4) metabolism that is activated by inhibitors of liver catalase. For this purpose, the metabolism of T4 in homogenates of rat liver was monitored with T4 labeled with 125I either at the 5'-position of the outer-ring (125I-beta-T4) or uniformly in both the outer and inner rings (125I-U-T4). In homogenates incubated with 125I-beta-T4 in an atmosphere of O2, the catalase inhibitor aminotriazole greatly enhanced T4 degradation, promoting the formation of large proportions of 125I-labeled iodide (125I-I-) and chromatographically immobile origin material (125I-OM), but only a minute proportion of 125I-labeled 3,5,3'-triiodothyronine (125I-T3) (T3 neogenesis). In an atmosphere of N2, in contrast, homogenates produced much larger proportions of 125I-T3, and aminotriazole had no effect. In incubations with 125I-U-T4, under aerobic conditions, control homogenates degraded T4 slowly; formation of 125I-labeled 3,5-diiodotyrosine (125I-DIT) was seen only occasionally and in minute proportions. However, in homogenates incubated under O2, but not N2, aminotriazole consistently elicited the formation of large proportions of 125I-DIT, indicating that the ether link of T4 was being cleaved by an O2-dependent process. Formation of 125I-DIT in the presence of aminotriazole and O2 was markedly inhibited by the substrates of peroxidase, aminoantipyrine, and guaiacol. GSH greatly attenuated the increase in DIT formation induced by aminotriazole, whereas the sulfhydryl inhibitor N-ethylmaleimide (NEM) activated the DIT-generating pathway, even in the absence of aminotriazole. Activation of the in vitro formation of 125I-DIT from 125I-U-T4 was also produced by the in vivo administration of aminotriazole or bacterial endotoxin, an agent that reduces hepatic catalase activity. Studies with 125I-DIT as substrate revealed it to be rapidly deiodinated by liver homogenates under aerobic conditions. Recovery of 125I-DIT from 125I-U-T4 was increased by the addition of the inhibitor of iodotyrosine dehalogenase, 3,5-dinitrotyrosine. However, as judged from studies conducted in parallel with radioiodine-labeled DIT and 125I-U-T4 as substrates, none of the factors that altered the proportion of 125I-DIT found after incubations with 125I-U-T4 did so by altering the degradation of the 125I-DIT formed. The factors that influenced DIT formation from T4 in rat liver had opposite effects on T3 neogenesis. Thus, aminotriazole, endotoxin, NEM, and an aerobic atmosphere, all of which enhanced DIT formation, were inhibitory to T3 neogenesis. In contrast, anaerobiosis and GSH inhibited ether-link cleavage of T4, but facilitated T3 neogenesis. The foregoing results suggest that a pathway for the ether-link cleavage of T4 to yield DIT is present in rat liver. Activity of this pathway, which appears to be peroxidase mediated, is inversely related to activity of the pathway for the T3 neogenesis. It is further suggested that this reciprocity reflects a reciprocal relationship between hepatic GSH and H2O2, the former increasing T3 formation and inhibiting DIT formation, and the latter producing opposite effects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630509      PMCID: PMC370407          DOI: 10.1172/JCI111079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Ion-exchange chromatographic analysis of iodothyronines.

Authors:  K Sorimachi; N Ui
Journal:  Anal Biochem       Date:  1975-07       Impact factor: 3.365

2.  Acceleration of thyroxine and triiodothyronine turnover during bacterial pulmonary infections and fever: implications for the functional state of the thyroid during stress and in senescence.

Authors:  R I Gregerman; N Solomon
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

Review 3.  Serum triiodothyronine in man.

Authors:  R D Utiger
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

4.  Metabolism of the diiodotyrosyl moiety of specifically labeled thyroxines.

Authors:  C S Pittman; T Maruyama; J B Chambers
Journal:  Endocrinology       Date:  1968-09       Impact factor: 4.736

5.  An improved method for chromatography of iodothyronines.

Authors:  D Bellabarba; R E Peterson; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1968-02       Impact factor: 5.958

6.  Inhibition of thyroidal iodotyrosine deiodination by tyrosine analogues.

Authors:  W L Green
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

7.  The carbon structure of thyroxine metabolites in urine.

Authors:  C S Pittman; J B Chambers
Journal:  Endocrinology       Date:  1969-04       Impact factor: 4.736

8.  Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine.

Authors:  I J Chopra; D H Solomon; U Chopra; R T Young; G N Chua Teco
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

9.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

10.  The integrity of the ether linkage during thyroxine metabolism in man.

Authors:  C S Pittman; V H Read; J B Chambers; H Nakafuji
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

View more
  6 in total

1.  Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.

Authors:  J S LoPresti; A Eigen; E Kaptein; K P Anderson; C A Spencer; J T Nicoloff
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

2.  Iodothyronines: oxidative deiodination by hemoglobin and inhibition of lipid peroxidation.

Authors:  Y L Tseng; K R Latham
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

Review 3.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 4.  Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.

Authors:  Rohit A Sinha; Eveline Bruinstroop; Brijesh K Singh; Paul M Yen
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

5.  Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents.

Authors:  P M Hurley
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

6.  Measurement of polybrominated diphenyl ethers and metabolites in mouse plasma after exposure to a commercial pentabromodiphenyl ether mixture.

Authors:  Xinghua Qiu; Minerva Mercado-Feliciano; Robert M Bigsby; Ronald A Hites
Journal:  Environ Health Perspect       Date:  2007-07       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.